Showing results (581-590 of 641) with videos related to

Sort By:
Pageof 65
Blood Advances|July 12, 2018
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remissionSumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
Innovation (Cambridge (Mass.))|November 12, 2024
Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemiaKellie J Archer, Han Fu, Krzysztof Mrózek, et al.
Blood|January 29, 2026
circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Blood Advances|March 8, 2021
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemiaChristopher J Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Leukemia|January 13, 2025
Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studiesNadeen Anabtawi, Deedra Nicolet, Najla Alotaibi, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 23, 2023
Routine transthoracic echocardiography in ischaemic stroke or transient ischaemic attack of undetermined cause: a prospective multicentre studyGerlinde van der Maten, Matthijs F L Meijs, Jorik R Timmer, et al.
Leukemia|November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemiaA-K Eisfeld, J Kohlschmidt, S Schwind, et al.
Journal of Hematology & Oncology|June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patientsAlice S Mims, Jessica Kohlschmidt, Uma Borate, et al.
Leukemia|February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance studyKrzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Pageof 65